| |
|
|
|
VistaGen Therapeutics Inc.  
|
|
1.3627 0.003 (0%) |
02-21 14:35 |
|
Open: |
1.37 |
Pre close: |
1.36 |
Target:
|
1.94
|
|
High: |
1.4628 |
Low: |
1.34 |
Resistance:
|
1.66
1.86
|
|
Volume: |
143,655 |
Market Cap: |
42M |
Support:
|
1.34
1.11
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.46
 |
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
1.60 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
1.74  |
Stochastic Oscillator |
%K(14,3):
|
6.25 |
|
MA(250): |
1.44 |
%D(3): |
9.23 |
|
Average Volume(K) |
3-Month: |
16211
|
52-Week |
High:
|
2.44 |
|
10-Days: |
26275 |
Low: |
0.81 |
|
RSI |
RSI(14):
|
35.30 |
Change(%): |
17.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.240 |
Return on Equity (ttm) |
-1733.3 |
Shares Out. (M) |
31.06 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-347.9 |
Shares Float (M) |
29.61 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.30 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
10.50 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
13.720 |
EBITDA (p.s.) |
0.000 |
P/E |
-1.13 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.10 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.57 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.55 |
P/CF |
-3.20 |
|
|
|
|
|
|
